# Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses

> **NCT01779102** · PHASE2,PHASE3 · COMPLETED · sponsor: **Statens Serum Institut** · enrollment: 456 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** C-Tb
- **BIOLOGICAL:** Tuberculin PPD RT 23 SSI
- **BIOLOGICAL:** C-Tb / Tuberculin PPD RT 23 SSI

## Key facts

- **NCT ID:** NCT01779102
- **Lead sponsor:** Statens Serum Institut
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 456 (ACTUAL)
- **Last updated:** 2015-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01779102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01779102, "Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01779102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*